Validation of a risk prediction model for Barrett's esophagus in an Australian population

Ireland, Colin J; Gordon, Andrea L; Thompson, Sarah K; Watson, David I; Whiteman, David C; Reed, Richard L; Esterman, Adrian
March 2018
Clinical & Experimental Gastroenterology;Mar2018, Vol. 11, p135
Academic Journal
Background: Esophageal adenocarcinoma is a disease that has a high mortality rate, the only known precursor being Barrett's esophagus (BE). While screening for BE is not cost-effective at the population level, targeted screening might be beneficial. We have developed a risk prediction model to identify people with BE, and here we present the external validation of this model. Materials and methods: A cohort study was undertaken to validate a risk prediction model for BE. Individuals with endoscopy and histopathology proven BE completed a questionnaire containing variables previously identified as risk factors for this condition. Their responses were combined with data from a population sample for analysis. Risk scores were derived for each participant. Overall performance of the risk prediction model in terms of calibration and discrimination was assessed. Results: Scores from 95 individuals with BE and 636 individuals from the general population were analyzed. The Brier score was 0.118, suggesting reasonable overall performance. The area under the receiver operating characteristic was 0.83 (95% CI 0.78-0.87). The Hosmer-Lemeshow statistic was p=0.14. Minimizing false positives and false negatives, the model achieved a sensitivity of 74% and a specificity of 73%. Conclusion: This study has validated a risk prediction model for BE that has a higher sensitivity than previous models.


Related Articles

  • Barrett's Esophagus on Repeat Endoscopy: Should We Look More Than Once? Rodriguez, Sarah; Mattek, Nora; Lieberman, David; Fennerty, Brian; Eisen, Glenn // American Journal of Gastroenterology;Aug2008, Vol. 103 Issue 8, p1892 

    BACKGROUND: Barrett's esophagus (BE) is the precursor lesion for esophageal adenocarcinoma. The major risk factor for BE is chronic gastroesophageal reflux disease (GERD). Screening patients with longstanding GERD for BE with upper esophagogastroduodenoscopy (EGD) has become the standard...

  • Common Questions About Barrett Esophagus. ZIMMERMAN, THOMAS G. // American Family Physician;1/15/2014, Vol. 89 Issue 2, p92 

    Barrett esophagus is a precancerous metaplasia of the esophagus that is more common in patients with chronic reflux symptoms, although it also occurs in patients without symptomatic reflux. Other risk factors include smoking, male sex, obesity, white race, hiatal hernia, and increasing age...

  • Fluorescence in situ hybridization identifies high risk Barrett's patients likely to develop esophageal adenocarcinoma. Brankley, S. M.; Halling, K. C.; Jenkins, S. M.; Timmer, M. R.; Iyer, P. G.; Smyrk, T. C.; Barr Fritcher, E. G.; Voss, J. S.; Kipp, B. R.; Campion, M. B.; Lutzke, L. S.; Minot, D. M.; Wang, K. K. // Diseases of the Esophagus;Aug/Sep2016, Vol. 29 Issue 6, p513 

    Barrett's esophagus ( BE) with high-grade dysplasia ( HGD) defines a group of individuals at high risk of progression to esophageal adenocarcinoma ( EA). Fluorescence in situ hybridization ( FISH) has been shown to be useful for the detection of dysplasia and EA in endoscopic brushing specimens...

  • Pathophysiology of Barrett's Esophagus-Associated Neoplasia: Circumferential Spatial Predilection. Ishimura, Norihisa; Okada, Mayumi; Mikami, Hironobu; Okimoto, Eiko; Fukuda, Naoki; Uno, Goichi; Aimi, Masahito; Oshima, Naoki; Ishihara, Shunji; Kinoshita, Yoshikazu // Digestion;Aug2014, Vol. 89 Issue 4, p291 

    The prevalence rates of Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC) arising from BE show striking geographic patterns as they are much more common in Western as compared with Asian countries. However, recent epidemiological studies indicate that the number of patients with BE...

  • Adenocarcinoma risk in patients registered with Polish Barrett's Oesophagus Registry. Januszewicz, Władysław; Kamiński, Michał F.; Wieszczy, Paulina; Wrońska, Ewa; Bielasik, Andrzej; Wojciechowska, Urszula; Didkowska, Joanna; Orłowska, Janina; Reguła, Jarosław // Diseases of the Esophagus;Jan2017, Vol. 30 Issue 1, p1 

    Barrett's Oesophagus (BO) is a complication of chronic gastro-oesophageal reflux disease (GORD) and is a major risk factor for oesophageal adenocarcinoma. Current guidelines are based on data showing a 0.5% annual malignancy progression rate. The Polish Barrett's Oesophagus Registry (POBOR) was...

  • Aspirin and Nonsteroidal Anti-Inflammatory Drug Use and the Risk of Barrett's Esophagus. Schneider, Jennifer; Zhao, Wei; Corley, Douglas // Digestive Diseases & Sciences;Feb2015, Vol. 60 Issue 2, p436 

    Background: The use of aspirin and nonsteroidal anti-inflammatory drugs (NSAIDs) may decrease the risk of esophageal adenocarcinoma; however, it is unknown where these agents may act in the proposed pathway from normal mucosa to Barrett's esophagus to esophageal adenocarcinoma. Aim: The aim of...

  • Extent of Low-Grade Dysplasia Is a Risk Factor for the Development of Esophageal Adenocarcinoma in Barrett's Esophagus. Srivastava, Amitabh; Hornick, Jason L.; Xiaohong Li; Blount, Patricia L.; Sanchez, Carissa A.; Cowan, David S.; Ayub, Kamran; Maley, Carlo C.; Reid, Brian J.; Odze, Robert D. // American Journal of Gastroenterology;Mar2007, Vol. 102 Issue 3, p483 

    OBJECTIVES: Previous studies that evaluated extent of high-grade dysplasia (HGD) as a risk factor for esophageal adenocarcinoma (EA) in Barrett's esophagus (BE) were conflicting, and no prior study has evaluated extent of low-grade dysplasia (LGD) as a risk factor. The aim of this discovery...

  • Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Reid, Brian J.; Xiaohong Li; Galipeau, Patricia C.; Vaughan, Thomas L.; Li, Xiaohong // Nature Reviews Cancer;Feb2010, Vol. 10 Issue 2, p87 

    The public health importance of Barrett's oesophagus lies in its association with oesophageal adenocarcinoma. The incidence of oesophageal adenocarcinoma has risen at an alarming rate over the past four decades in many regions of the Western world, and there are indications that the incidence of...

  • Clustering of esophageal cancer among white men in the United States. Rubenstein, J H; Morgenstern, H; Longstreth, K // Diseases of the Esophagus;Jan2019, Vol. 32 Issue 1, pN.PAG 

    Studies of the geographic distribution of esophageal cancer in the United States have been limited. We aimed to examine geographic clustering of esophageal cancer in the United States and assess whether that clustering is explained by the distribution of known risk factors for esophageal cancer....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics